Pfizer, Eli Lilly, and Abbott Laboratories are competing in the global biopharmaceutical market and are being tracked by MarketBeat stock screeners.
2 reports, 2 independent
Updated Sep 23
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Pfizer, Eli Lilly, and Abbott Laboratories are competing in the global biopharmaceutical market and are being tracked by MarketBeat stock screeners.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Pfizer
American multinational pharmaceutical and biotechnology corporation
-
Eli Lilly and Company
American pharmaceutical company
-
Abbott Laboratories
American global health care and medical device products company
Nothing else this week.
Related events
- AbbVie and Eli Lilly are competing in the pharmaceutical market.
- Abbott Laboratories was featured as one of five stocks to watch on MarketBeat on May 26, 2026.
- Pfizer's performance is being analyzed in comparison to the broader market.
- A group of major pharmaceutical companies, including AbbVie, Bristol-Myers Squibb, Amgen, Pfizer, Moderna, and Merck, are noted as peers operating in the highly regulated pharmaceutical sector.
- Major pharmaceutical companies are competing for investment capital.